Skip to main content

Dr. Richard Malamut

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dr. Richard Malamut

Dr. Richard Malamut is recorded as Board Member at Pelthos Therapeutics Inc. (PTHS). Pelthos Therapeutics Inc. reported in an 8-K filed October 1, 2026 that Dr. Richard Malamut was appointed director, effective September 29, 2026. Pelthos Therapeutics Inc. reported in an 8-K filed July 2, 2025 that Dr. Richard Malamut was appointed director, effective July 1, 2025.

“The eight (8) nominees named in the Proxy Statement were elected to serve as the Company’s directors until the Company’s 2027 Annual Meeting of Stockholders, or until each of their respective successors are elected and qualified or until their earlier resignation or removal.”
Pelthos Therapeutics Inc. Form 8-K, filed October 1, 2026 · Read the filing
“At the Effective Time, one director selected by the Company, namely Dr. Richard Malamut, one director who is the newly-elected Chief Executive Officer of the Company, namely Scott Plesha, four directors selected by LNHC, namely Peter Greenleaf, Matthew Pauls, Todd Davis and Richard Baxter, and one member selected by Nomis Bay, namely Ezra Friedberg, were each appointed to serve as a director of the Company until the next annual meeting of stockholders to be held after the Closing Date or until a successor is duly elected and qualified, or until each such director’s earlier resignation or removal.”
Pelthos Therapeutics Inc. Form 8-K, filed July 2, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Pelthos Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.